| 2021-05 | DRUG CO
Specimen Collection Study to Evaluate Biomarkers in Subjects with or without Cancer
NCT05008848 | A211901 | ALLIANCE
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Cessation Interventions
NCT05334069 | A212102 | ALLIANCE
Blinded Reference Set For Multicancer Early Detection Blood Tests
NCT03067181 | AGCT1531 | COG-AYA
A Phase 3 Study of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients with Germ Cell Tumors
NCT04871542 | S2013 | SWOG
Immune Checkpoint Inhibitor Toxicity (I-CHECKIT): A Prospective Observational Study
NCT06073431 | URCC-22063 | URCC
Longitudinal Observational Trial to Uncover Subtypes of Cancer Cachexia
NCT05564377 | EAY191 | ECOG
Molecular Analysis for Combination Therapy Choice (ComboMATCH)
NCT05006482 | URCC-19178 | URCC
Optimizing Functional Outcomes of Older Cancer Survivors After Chemotherapy (GEMS)
NCT06513962 | ALTE2131 | COG-AYA
Triptorelin and Protection of Ovarian Reserve in Adolescents and Young Adults with Cancer
NCT06418204 | WF2304/A172401 | WAKE
Complementary Options for Symptom Management In Cancer (COSMIC): Assessing Benefits and Harms of Cannabis and Cannabinoid Use Among a Cohort of Cancer Patients Treated in Community Oncology Clinics